Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1
- PMID: 28180185
- PMCID: PMC5289017
- DOI: 10.1212/NXG.0000000000000130
Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1
Abstract
Objective: ATAD1 encodes Thorase, a mediator of α-amino-3-hydroxy-5-methylisoxazole-4-proprionate (AMPA) receptor recycling; in this work, we characterized the phenotype resulting from ATAD1 mutations and developed a targeted therapy in both mice and humans.
Methods: Using exome sequencing, we identified a novel ATAD1 mutation (p.E276X) as the etiology of a devastating neurologic disorder characterized by hypertonia, seizures, and death in a consanguineous family. We postulated that pathogenesis was a result of excessive AMPA receptor activity and designed a targeted therapeutic approach using perampanel, an AMPA-receptor antagonist.
Results: Perampanel therapy in ATAD1 knockout mice reversed behavioral defects, normalized brain MRI abnormalities, prevented seizures, and prolonged survival. The ATAD1 patients treated with perampanel showed improvement in hypertonicity and resolution of seizures.
Conclusions: This work demonstrates that identification of novel monogenic neurologic disorders and observation of response to targeted therapeutics can provide important insights into human nervous system functioning.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5289017/bin/NG2016003863FF1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5289017/bin/NG2016003863FF2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5289017/bin/NG2016003863FF3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5289017/bin/NG2016003863FF4.gif)
Similar articles
-
A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy.Brain. 2018 Mar 1;141(3):651-661. doi: 10.1093/brain/awx377. Brain. 2018. PMID: 29390050 Free PMC article.
-
Thorase variants are associated with defects in glutamatergic neurotransmission that can be rescued by Perampanel.Sci Transl Med. 2017 Dec 13;9(420):eaah4985. doi: 10.1126/scitranslmed.aah4985. Sci Transl Med. 2017. PMID: 29237760 Free PMC article.
-
Congenital immobility and stiffness related to biallelic ATAD1 variants.Neurol Genet. 2020 Sep 24;6(6):e520. doi: 10.1212/NXG.0000000000000520. eCollection 2020 Dec. Neurol Genet. 2020. PMID: 33134516 Free PMC article.
-
Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures.Expert Opin Pharmacother. 2013 Feb;14(2):225-35. doi: 10.1517/14656566.2013.754883. Epub 2012 Dec 23. Expert Opin Pharmacother. 2013. PMID: 23259931 Review.
-
Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.Acta Neurol Scand. 2018 Apr;137(4):378-391. doi: 10.1111/ane.12879. Epub 2017 Dec 7. Acta Neurol Scand. 2018. PMID: 29214650 Review.
Cited by
-
Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction.Elife. 2022 Nov 21;11:e82860. doi: 10.7554/eLife.82860. Elife. 2022. PMID: 36409067 Free PMC article.
-
Markhor-derived Introgression of a Genomic Region Encompassing PAPSS2 Confers High-altitude Adaptability in Tibetan Goats.Mol Biol Evol. 2022 Dec 5;39(12):msac253. doi: 10.1093/molbev/msac253. Mol Biol Evol. 2022. PMID: 36382357 Free PMC article.
-
ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson's Disease-like Behavior.Cells. 2022 Sep 26;11(19):2990. doi: 10.3390/cells11192990. Cells. 2022. PMID: 36230952 Free PMC article.
-
AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1.Nat Commun. 2022 Aug 17;13(1):4836. doi: 10.1038/s41467-022-32365-2. Nat Commun. 2022. PMID: 35977929 Free PMC article.
-
Startle Disease: New Molecular Insights into an Old Neurological Disorder.Neuroscientist. 2023 Dec;29(6):767-781. doi: 10.1177/10738584221104724. Epub 2022 Jun 25. Neuroscientist. 2023. PMID: 35754344 Free PMC article. Review.
References
-
- Srivastava S, Cohen JS, Vernon H, et al. . Clinical whole exome sequencing in child neurology practice. Ann Neurol 2014;76:473–483. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases